Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2021-04-15 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
关于执行新会计准则并变更相关会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about the adoption of new accounting standards and changes in accounting policies. It details the reasons for the change, the date of implementation, the impact on financial statements, and includes opinions from the board of directors, supervisory board, and independent directors. The document does not contain actual financial statements or detailed financial data but rather informs stakeholders about the policy change and compliance with regulatory requirements. The document length is relatively short (1972 characters), and it serves as a formal announcement rather than a full financial report or audit. Therefore, it fits best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-04-15 Chinese
关于修改公司经营范围及修订公司章程的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding changes to the company's business scope and amendments to the company bylaws (章程). It details resolutions passed by the board of directors and mentions that these changes will be submitted to the shareholders' meeting for approval. The document does not contain financial statements, audit results, or detailed financial data. It is a formal corporate announcement about governance and operational scope changes, not a full report or financial filing. This fits best under Board/Management Information (MANG), which covers announcements of changes in company governance or management-related decisions. The document length is 3224 characters, which is relatively short and consistent with an announcement rather than a full report.
2021-04-15 Chinese
关于公司2021年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 康泰医学系统（秦皇岛）股份有限公司 regarding the expected related party transactions for the year 2021. It details the nature of the transactions, the parties involved, pricing principles, and includes opinions from independent directors and the sponsoring institution. The document is an announcement about anticipated related party transactions rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis. The length is about 3310 characters, which is relatively short and typical for an announcement. Therefore, this document fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2021-04-15 Chinese
独立董事关于公司控股股东及其他关联方占用公司资金、公司对外担保情况等事项的专项说明和独立意见
Audit Report / Information Classification · 95% confidence The document is a special statement and independent opinion by the independent directors of 康泰医学系统（秦皇岛）股份有限公司 regarding the company's related party fund occupation and external guarantees during the 2020 fiscal year. It references regulatory guidelines from the China Securities Regulatory Commission and discusses compliance and findings related to related party transactions and guarantees. The document is short (679 characters) and serves as a formal independent directors' statement rather than a full audit report or annual report. It is a standalone audit-related opinion on specific matters, fitting the category of Audit Report / Information (AR). FY 2020
2021-04-15 Chinese
2020年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2020年度监事会工作报告" which translates to "2020 Supervisory Board Work Report". It details the supervisory board's activities, meetings, resolutions, and oversight of the company's operations, financials, internal controls, and compliance with laws and regulations during the 2020 fiscal year. The content includes detailed supervisory opinions on financial reports, internal controls, fundraising usage, and governance matters. It is a comprehensive report from the supervisory board rather than an announcement or a brief summary. The document length is 3279 characters, which is relatively short but contains substantive content and detailed supervisory analysis. This type of report aligns with a Management Report (MDA) as it provides management's detailed explanation and oversight of financial results, business trends, and governance for the year. It is not an Annual Report (10-K) or Audit Report (AR) because it focuses on supervisory board work and oversight rather than full financial statements or audit opinions alone. It is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains substantive content rather than just an announcement. Therefore, the best classification is Management Reports (MDA).
2021-04-15 Chinese
2020年度独立董事述职报告（彭勇）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2020 Annual Report" for 康泰医学系统（秦皇岛）股份有限公司. It details the independent director's duties, attendance at board and shareholder meetings, opinions on various board resolutions, committee work, on-site investigations, and efforts to protect investor rights during the 2020 fiscal year. The content is a detailed report of the independent director's activities and responsibilities over the year, not a general annual report or financial statement. It is not a certification, announcement, or proxy material. This fits the category of Board/Management Information (MANG), which includes announcements or reports related to board members and senior management activities. The document length is 3520 characters, which is sufficient for a detailed report but not a full annual report. Therefore, the best classification is MANG with high confidence.
2021-04-15 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.